Biotechnology
Magdalena Biosciences is a seed-stage joint venture formed by Jaguar Health and Filament Health with foundational funding from One Small Planet. The company develops novel, plant-derived, pharmaceutical-grade prescription medicines for mental health disorders, initially focusing on adult ADHD, depression, and anxiety. Magdalena leverages Jaguar's proprietary library of 2,300 highly characterized medicinal plants and Filament's advanced drug development technology to build revolutionary drugs from whole-extract coca leaf, offering safe, novel mechanisms of action compared to chemically synthesized small-molecule drugs. The company is preparing for Series A financing and is positioned to transform botanical innovation into validated, commercializable clinical pipelines.
Industry
Biotechnology
Company Size
1-10 employees
Remote Policy
Fully Remote
Beta · Sourced from candidate reports
Be the first to share your experience with Magdalena Biosciences.
Your reply helps other candidates know what to expect.
